Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dendritic cells: at the clinical crossroads.

× No keyword cloud information.

14 in total

1. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo.

Authors: G J Randolph; K Inaba; D F Robbiani; R M Steinman; W A Muller
Journal: Immunity Date: 1999-12 Impact factor: 31.745

Review 2. Dendritic cells and the control of immunity.

Authors: J Banchereau; R M Steinman
Journal: Nature Date: 1998-03-19 Impact factor: 49.962

3. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.

Authors: N Bhardwaj; A Bender; N Gonzalez; L K Bui; M C Garrett; R M Steinman
Journal: J Clin Invest Date: 1994-08 Impact factor: 14.808

4. Protective antiviral cytotoxic T cell memory is most efficiently maintained by restimulation via dendritic cells.

Authors: B Ludewig; S Oehen; F Barchiesi; R A Schwendener; H Hengartner; R M Zinkernagel
Journal: J Immunol Date: 1999-08-15 Impact factor: 5.422

5. Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes.

Authors: M V Dhodapkar; J Krasovsky; R M Steinman; N Bhardwaj
Journal: J Clin Invest Date: 2000-03 Impact factor: 14.808

6. Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen.

Authors: G Murphy; B Tjoa; H Ragde; G Kenny; A Boynton
Journal: Prostate Date: 1996-12 Impact factor: 4.104

7. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.

Authors: F O Nestle; S Alijagic; M Gilliet; Y Sun; S Grabbe; R Dummer; G Burg; D Schadendorf
Journal: Nat Med Date: 1998-03 Impact factor: 53.440

8. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells.

Authors: F J Hsu; C Benike; F Fagnoni; T M Liles; D Czerwinski; B Taidi; E G Engleman; R Levy
Journal: Nat Med Date: 1996-01 Impact factor: 53.440

9. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.

Authors: D Bell; P Chomarat; D Broyles; G Netto; G M Harb; S Lebecque; J Valladeau; J Davoust; K A Palucka; J Banchereau
Journal: J Exp Med Date: 1999-11-15 Impact factor: 14.307

10. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma.

Authors: B Thurner; I Haendle; C Röder; D Dieckmann; P Keikavoussi; H Jonuleit; A Bender; C Maczek; D Schreiner; P von den Driesch; E B Bröcker; R M Steinman; A Enk; E Kämpgen; G Schuler
Journal: J Exp Med Date: 1999-12-06 Impact factor: 14.307

5 in total

1. Specifically activated dendritic cells--cell-based vaccine against lymphosarcoma exhibiting multiple drug resistance phenotype.

Authors: N L Mironova; E E Panzinskyi; N A Popova; V P Nikolin; M A Zenkova; V V Vlasov
Journal: Dokl Biochem Biophys Date: 2009 Sep-Oct Impact factor: 0.788

Dendritic cells: at the clinical crossroads.